Home

 Company Profile News & Events Scientific Programme Licensing AIM Rule 26 Feedback Contact Us
 

13 Mar 2008

 

CHANGE OF BROKER
 

The Directors of Henderson Morley plc, the drug discovery company, are pleased to announce the appointment of Hybridan LLP as the Company’s sole broker  with immediate effect.

 

Brewin Dolphin remains the Company’s Nominated Adviser.

 
       

Home | Company Profile  | News & Events  | Scientific Programme | Licensing  | Investor Relations  | Feedback  | Contact Us